脓毒症的发生、发展及预后与机体免疫调控密切相关，免疫代谢是近年来脓毒症免疫干预的研究热点。AMP活化蛋白激酶(AMP-activated protein kinase，AMPK)/哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin，mTOR)是机体代谢调控的经典信号通路，参与中性粒细胞趋化性、巨噬细胞极化、自然杀伤性细胞和树突状细胞的发育分化、T细胞发育及功能调节，是脓毒症免疫代谢调控的重要途径。本文就AMPK-mTOR信号通路调节免疫细胞代谢重编程参与脓毒症免疫调节的研究进展做一综述。“,”The occurrence, development and prognosis of sepsis are closely related to immune regulation.Immunometabolism has been the research hotspot of immune intervention in sepsis in recent years.AMP-activated protein kinase(AMPK)and mammalian target of rapamycin(mTOR)are star molecules involved in metabolic regulation.As an important way of immunometabolic regulation in sepsis, AMPK-mTOR is involved in the process of chemotaxis of neutrophils, the polarization of macrophages, the development and differentiation of natural killer cells and dendritic cells, and the development and functional regulation of T cells.This article reviewed the research progress of AMPK-mTOR signaling pathway on regulating metabolic reprogramming in immune cells, which contributes to immunoregulation in sepsis.